학술논문
A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14320843